L‐Tryptophan is the unique protein amino acid (AA) bearing an indole ring: its
biotransformation in living organisms contributes either to keeping this chemical group in …

Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The worldwide effort to develop peptide …

Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The Food and Drug Administration has …

Protein misfolding into amyloid fibrils is linked to more than 40 as yet incurable cell‐and
neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and type 2 …

Bioactive peptides are actively involved in different biological functions and importantly
contribute to human health, and the use of peptides as therapeutics has a long successful …

Aggregation of amyloid β-protein (Aβ) into amyloid oligomers and fibrils is pathologically
linked to Alzheimer's disease (AD). Hence, the inhibition of Aβ aggregation is essential for …

Accumulation of amyloid beta (Aβ) peptide and its aggregates in the human brain is
considered as one of the hallmarks of Alzheimer's disease (AD). The polymorphic oligomers …

Alzheimer disease (AD) is the most common progressive neurodegenerative disorder. AD
causes enormous personal and economic burden to society as currently only limited …

The aging population increases steadily because of a healthy lifestyle and medical
advancements in healthcare. However, Alzheimer's disease (AD) is becoming more …

In the last two decades, the amyloid hypothesis, ie, the abnormal accumulation of toxic Aβ
assemblies in the brain, has been considered the mainstream concept sustaining research …